Related Experiment Video
Updated: May 20, 2026
A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
Are patients with inflammatory bowel disease at increased risk of coronary artery disease?
Sumeet Gandhi1, Neeraj Narula, John K Marshall
1Department of Medicine, University of Toronto, Ontario, Canada.
Insights
Patients with inflammatory bowel disease (IBD) face higher coronary artery disease (CAD) risks, even without typical risk factors. Inflammation markers may predict CAD, and some cardiovascular drugs might offer dual benefits for IBD and CAD.
Area of Science:
- Cardiovascular Medicine
- Gastroenterology
- Immunology
Background:
- Chronic inflammatory diseases are linked to increased coronary artery disease (CAD) risk.
- Inflammatory bowel disease (IBD) is a chronic inflammatory condition.
- Existing literature suggests a connection between IBD and CAD.
Purpose of the Study:
- To systematically review the association between inflammatory bowel disease and coronary artery disease.
- To identify risk factors for CAD in IBD patients.
- To explore potential therapeutic strategies for both conditions.
Main Methods:
- Systematic literature search for peer-reviewed studies on IBD and CAD.
- Analysis of identified studies focusing on risk factors and associations.
- Review of potential dual-acting therapeutic agents.
Main Results:
- An association between inflammatory bowel disease and coronary artery disease is supported by recent literature.
- Hypertension is a confirmed risk factor for CAD in IBD patients.
- Inflammation markers may predict CAD risk in this population, while other traditional risk factors are less confirmed.
Conclusions:
- Physicians should consider increased CAD risk in IBD patients, even without traditional risk factors.
- Primary preventive strategies for CAD are recommended for IBD patients.
- Cardiovascular drugs like statins and ACE inhibitors may offer dual benefits for IBD and CAD management.
- Further large, prospective, longitudinal studies are needed to confirm prevalence and risk factors.
Abstract:
The inflammatory state of atherosclerosis has been established as those with chronic inflammatory diseases, such as rheumatoid arthritis and systemic lupus erythematosus, who are at increased risk of coronary artery disease. A systematic search was conducted to retrieve high-quality, peer-reviewed studies of inflammatory bowel disease and coronary artery disease. Recent literature supports an association between inflammatory bowel disease and coronary artery disease. While hypertension increases the risk of coronary artery disease in inflammatory bowel disease patients, other typical risk factors have not been confirmed, and markers of inflammation may predict coronary artery disease risk in this population. Common cardiovascular drugs such as statins and angiotensin-converting enzyme inhibitors may have dual potential for controlling inflammatory bowel disease and preventing or treating coronary artery disease. Large, prospective, longitudinal studies can help to determine the true prevalence of coronary artery disease in this population and confirm risk factors. In the absence of such evidence, physicians should be cognizant of increased coronary artery disease risk in inflammatory bowel disease patients without traditional risk factors and consider primary preventive strategies.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:26Inflammatory Bowel Disease I: Introduction